PathAI develops artificial intelligence software and digital pathology systems used in diagnostic workflows, clinical research, and drug development. The company provides AI-powered tools that analyze tissue samples and pathology images to support biomarker discovery, disease characterization, and laboratory operations. Its platform includes AISight, a digital pathology image management system used for case review, image analysis, workflow coordination, and integration of AI applications into pathology environments. PathAI also offers laboratory services, pathology data analysis, and machine learning models designed for clinical trials and pharmaceutical research. The company collaborates with healthcare organizations, pathology laboratories, and biopharmaceutical companies to support precision medicine and pathology digitization initiatives. Its technology is applied in areas such as oncology, liver disease research, companion diagnostics, and pathology workflow automation.